http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113577372-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a21556b7c23c3933e3a7aa14798cd6a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-046
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
filingDate 2021-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bea557d827999ac47082c99498ace31
publicationDate 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113577372-A
titleOfInvention A kind of medical hemostatic composite material and preparation method thereof
abstract The invention discloses a medical hemostatic composite material, comprising the following raw materials: 30-60 parts of self-made modified composite polysaccharide solution, 1-3 parts of gum arabic, 1-4 parts of gelatin, 1-4 parts of sodium hyaluronate, 5- 12 parts calcium chloride, 2-4 parts stearic acid, 2-8 parts polyethylene glycol, 0.5-4 parts polyoxyethylene sorbitan monooleate, 2-4 parts glycerol monolaurate, 10 parts -20 parts of glycerol, 0.5-2 parts of hydrogen peroxide, 0.5-2 parts of tannic acid, and 45-70 parts of deionized water, the invention also discloses a preparation method of the medical hemostatic composite material. The material has good hemostatic and antibacterial effects.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114605570-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114605570-B
priorityDate 2021-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108904875-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109400968-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018110897-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412667134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457765275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16134267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410916410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453213080

Total number of triples: 46.